Clinical Trial Update: Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome [NA]

View source ↗

Summary

A completed clinical trial assessing the effects of medium-chain triglycerides on chylomicron secretion and expression of genes regulating intestinal lipid meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Metabolic Syndrome

Drugs mentioned

• Medium Chain Triglycerides (Medium-chain triglycerides)

Snippet

Sponsor: Laval University | Conditions: Metabolic Syndrome X | NA | Status: COMPLETED